SI
SI
discoversearch

Biotech / Medical
DYAX: Dyax Corp.
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
195 22 0 DYAX
Emcee:  SI (no user) Type:  Moderated
This message board is intended for discussion of DYAX: Dyax Corp..
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1956:32AM Dyax and Sigma-Tau announce partnership to develop and commercialize subcmlkr-6/21/2010
194<i>>They'd better stick to what they know best - antibiotics.<&lDewDiligence_on_SI-4/1/2010
193They'd better stick to what they know best - antibiotics.idos-4/1/2010
192Cubist's track record with inlicensing has been atrocious.rkrw-4/1/2010
191It was no big surprised if even I could see it coming back in Dec: investorshubidos-4/1/2010
1901K shares of it were hanging on arca at about the close for a few minutes after scaram(o)uche-3/31/2010
189>>Cubist Pharmaceuticals to End Development of CB-500,929 Decision followstuck-3/31/2010
188CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX - News) announced todnigel bates-12/2/2009
187CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX - News) announced tonigel bates-10/13/2009
186>>Dyax Receives Complete Response Letter from FDA for DX-88 in Acute Attactuck-3/26/2009
185DYAX said in its Q4 CC that the focus of their discussions with FDA is a "sidos-2/25/2009
184Dyax Announces Expansion of Antibody Discovery Collaboration with Biogen Idec Thnigel bates-2/5/2009
183Panel voted 6-5 (2 abstentions) to approve. They voted (8-5) that the drug is efidos-2/5/2009
182Yes or no vote? First notice from ScotTrade said this had failed on a 5 to 6 voSteve Lokness-2/4/2009
181Cinryze was approved as an orphan drug for prophylactic treatment of HAE and sinidos-11/23/2008
180Hasn't Lev already beat them to market and attained the orphan exclusivity? mcbio-11/22/2008
179FDA has accepted for filing the BLA for DX-88 (ecallantide) for the treatment ofidos-11/21/2008
178Dyax announced completion of BLA for DX-88 for HAE and has requested Priority Reidos-9/24/2008
177DX-88 has successfully completed EDEMA4 trial. No allergic reactions were found.idos-8/18/2008
176GENZ once owned half the rights to this program but relinquished them to Dyax foDewDiligence_on_SI-4/25/2008
175<i>Thought I'd mention Jerini's whiff, though, since no one else hDewDiligence_on_SI-4/24/2008
174Maybe the market is negative because Dyax reported a net loss of $21.3M, ended Qidos-4/24/2008
173Delidos-4/24/2008
172Interesting that the market doesn't think much of this deal. Perhaps becaustuck-4/24/2008
171<b>Dyax, Cubist Ink R&D Deal for Blood-Loss Drug</b> thestreet.idos-4/24/2008
170<b>Companies line up for hereditary angioedema market</b> Brady Hugidos-4/14/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2014 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.